Cystoid macular edema after primary anterior chamber intraocular lens implants following posterior capsule rent

Session Details

Session Title: Cataract Surgery: Complications & Management

Session Date/Time: Tuesday 17/09/2019 | 14:00-16:00

Paper Time: 15:02

Venue: Free Paper Forum: Podium 1

First Author: : S.Ti SINGAPORE

Co Author(s): :    Y. Yang   S. Chee                          

Abstract Details

Purpose:

To study the management and outcomes of patients with clinically significant cystoid macula edema (CSCME) following cataract surgery with vitreous loss and anterior chamber intraocular lens (AC-IOL) implants.

Setting:

Singapore National Eye Centre, Singapore

Methods:

Clinical course of all eyes who developed CSCME following primary AC-IOL (MTA4UO 13mm) implantation for cataract surgery complicated by posterior capsule rupture (2013-2015) were retrospectively audited. Type of cataract, best-corrected visual acuity (BCVA at 1year) and treatment durations were reviewed.

Results:

Fourteen of 119 AC-IOL cases had CSCME, the most common complication. BCVA: 20/40 (n=5, 35.7%); 20/70-20/80 (4); 20/100-20/150 (5); CSCME onset = 1-21 months; 11 cases > 6 months duration. Ocular profile : small pupil, pseudoexfoliation (5); dense subluxated (4) & polar (1) cataracts. Treatment: topical steroids & NSAIDS 3-6 weeks, +/- followed by NSAIDs only 2-18 months (mean 8 months). CME recurred if NSAIDS < 2 months. CME was associated with cornea decompensation (2), diabetic CSME & epiretinal membrane (4); dropped lens material (2). Three eyes resolved after AC-IOL exchange for haptic-cornea touch, cornea edema and recurrent uveitis.

Conclusions:

Chronic CSCME is a significant complication following cataract surgery with AC-IOL which may lead to visual impairment. In intractable cases, AC-IOL removal facilitates resolution of CSCME.

Financial Disclosure:

None